Literature DB >> 30720220

Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction.

Xu-He Gong1, Hui Liu2, Si-Jia Wang3, Si-Wen Liang1, Guo-Gan Wang2.   

Abstract

Exosomes extracted from mesenchymal stem cells (MSCs) was reported to reduce myocardial ischemia/reperfusion damage. Besides, stromal-derived factor 1 (SDF1a) functions as cardiac repair after myocardial infarction (MI). Therefore, the present study aims to identify whether exosomes (Exo) released from SDF1-overexpressing MSCs display a beneficial effect on ischemic myocardial infarction. Initially, a gain-of-function study was performed to investigate the function of SDF1 in ischemic myocardial cells and cardiac endothelial cells. Coculture experiments were performed to measure potential exosomic transfer of SDF1 from MSCs to ischemic myocardial cells and cardiac endothelial cells. During the coculture experiments, exosome secretion was disrupted by neutral sphingomyelinase inhibitor GW4869 and upregulated exosomal SDF1 using SDF1 plasmid. Effects of Exo-SDF1 on cardiac function in MI mice were investigated in vivo. MSCs suppressed myocardial cell apoptosis and promoted microvascular regeneration of endothelial cells through secretion of exosomes. The addition of GW4869 led to increased apoptotic capacity of myocardial cells, decreased microvascular formation ability of endothelial cells, enhanced autophagy ability, and elevated Beclin-1 level as well as ratio of LC3II/LC3I. Overexpression of SDF1 and Exo-SDF1 inhibited apoptosis and autophagy of myocardial cells, but promoted tube formation of endothelial cells. The interference of PI3K signaling pathway promoted apoptosis and autophagy of myocardial cells, but inhibited tube formation of endothelial cells. SDF1 activated the PI3K signaling pathway. Exo-SDF1 protected cardiac function of MI mice and inhibited myocardial tissue damage. This study provided evidence that SDF1 overexpression in MSCs-derived exosomes inhibited autophagy of ischemic myocardial cells and promoted microvascular production of endothelial cells.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  apoptosis; autophagy; exosomes; mesenchymal stem cells; microvascular regeneration; myocardial infarction; stromal cell-derived factor 1

Mesh:

Substances:

Year:  2019        PMID: 30720220     DOI: 10.1002/jcp.28070

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  40 in total

Review 1.  Modulation of Stem Cells as Therapeutics for Severe Mental Disorders and Cognitive Impairments.

Authors:  Yongbo Zhang; Yingying Zhao; Xiaopeng Song; Hua Luo; Jinmei Sun; Chunyu Han; Xiaohuan Gu; Jun Li; Guilan Cai; Yanbing Zhu; Zhandong Liu; Ling Wei; Zheng Zachory Wei
Journal:  Front Psychiatry       Date:  2020-04-30       Impact factor: 4.157

Review 2.  Mechanism and therapeutic strategies of depression after myocardial infarction.

Authors:  Ying Yang; Xuping Li; Sixuan Chen; Mingzhu Xiao; Zhongqiu Liu; Jingyan Li; Yuanyuan Cheng
Journal:  Psychopharmacology (Berl)       Date:  2021-02-16       Impact factor: 4.530

Review 3.  Exosomes in Myocardial Infarction: Therapeutic Potential and Clinical Application.

Authors:  Wenjian Nian; Cong Fu
Journal:  J Cardiovasc Transl Res       Date:  2022-06-07       Impact factor: 4.132

4.  Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis.

Authors:  Libo Yang; Ting Wang; Xiaoxia Zhang; Hua Zhang; Ning Yan; Guoshan Zhang; Ru Yan; Yiwei Li; Jingjing Yu; Jun He; Shaobin Jia; Hao Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-02-17       Impact factor: 2.298

Review 5.  Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review).

Authors:  Jiejie Li; Yuanyuan Zhao; Wei Zhu
Journal:  Exp Ther Med       Date:  2021-11-22       Impact factor: 2.447

Review 6.  New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases.

Authors:  Lamiaa Ahmed; Khaled Al-Massri
Journal:  Tissue Eng Regen Med       Date:  2022-07-22       Impact factor: 4.451

7.  Effectiveness of exosome mediated miR-126 and miR-146a delivery on cardiac tissue regeneration.

Authors:  Shilan Shafei; Mehdi Khanmohammadi; Hossein Ghanbari; Vajihe Taghdiri Nooshabadi; Seyed Hossein Ahmadi Tafti; Sharam Rabbani; Maniya Kasaiyan; Mohsen Basiri; Gholamreza Tavoosidana
Journal:  Cell Tissue Res       Date:  2022-07-05       Impact factor: 4.051

Review 8.  Engineering of Immune Microenvironment for Enhanced Tissue Remodeling.

Authors:  Ga Ryang Ko; Jung Seung Lee
Journal:  Tissue Eng Regen Med       Date:  2022-01-18       Impact factor: 4.169

Review 9.  The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes.

Authors:  Soudeh Ghafouri-Fard; Vahid Niazi; Bashdar Mahmud Hussen; Mir Davood Omrani; Mohammad Taheri; Abbas Basiri
Journal:  Front Cell Dev Biol       Date:  2021-07-07

Review 10.  Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion.

Authors:  Xun Wu; Chukwuemeka Daniel Iroegbu; Jun Peng; Jianjun Guo; Jinfu Yang; Chengming Fan
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.